E71.541 Zellweger-like syndrome

Name of the Condition

• Zellweger-like syndrome

Summary

Zellweger-like syndrome is a rare genetic disorder affecting peroxisome function, leading to metabolic and neurological abnormalities. Peroxisomes are cellular organelles involved in breaking down fatty acids, producing bile acids, and detoxifying harmful substances. The condition results from impaired peroxisomal activity, causing the accumulation of toxic compounds and deficiency of essential metabolites, which can impact multiple organ systems.

Causes

Zellweger-like syndrome is caused by mutations in genes responsible for peroxisome biogenesis or function. These mutations disrupt the organelle's ability to perform its metabolic roles, leading to the buildup of substances like very long-chain fatty acids or the deficiency of plasmalogens, which are critical for brain and lung function. The specific genetic mutations vary and may affect proteins involved in peroxisome assembly or enzyme activity.

Risk Factors

• Autosomal recessive inheritance pattern.
• Family history of peroxisomal disorders.
• Consanguineous relationships (parents who are closely related).

Symptoms

• Developmental delays or regression.
• Muscle weakness or hypotonia.
• Seizures or abnormal eye movements.
• Liver dysfunction or enlarged liver.
• Abnormal facial features in some subtypes.
• Respiratory or feeding difficulties in infancy.

Diagnosis

Diagnosis involves clinical evaluation of physical features, biochemical testing to measure levels of very long-chain fatty acids, plasmalogens, or other peroxisomal metabolites in blood or urine, and genetic testing to confirm specific mutations. Radiographic imaging may detect bone abnormalities, and ophthalmologic exams can identify cataracts or retinal changes.

Treatment Options

Treatment is supportive and focuses on managing symptoms. This may include physical therapy for muscle weakness, seizure management, nutritional support, and monitoring for liver or respiratory complications. No cure exists, but early intervention can improve quality of life.

Prognosis and Follow-Up

Prognosis is generally poor, with most affected individuals having a shortened lifespan due to severe neurological and metabolic complications. Regular follow-up with a multidisciplinary team, including neurologists, geneticists, and metabolic specialists, is essential to monitor organ function and adjust care as needed.

Complications

• Severe neurological impairment.
• Liver failure.
• Respiratory distress.
• Feeding difficulties.
• Vision or hearing loss.

Lifestyle & Prevention

Genetic counseling is recommended for families with a history of peroxisomal disorders. Prenatal testing or carrier screening may be considered for at-risk pregnancies. Supportive care, such as physical therapy and nutritional management, can help address developmental and functional challenges.

When to Seek Professional Help

Seek medical attention if symptoms like developmental delays, seizures, or feeding difficulties appear in infancy. Early diagnosis and intervention are critical for managing complications and improving outcomes.

Tips for Medical Coders

Document clinical findings, genetic test results, and peroxisomal metabolite levels to support the diagnosis. Ensure the code E71.541 is used for Zellweger-like syndrome, and include details about peroxisomal dysfunction or specific genetic mutations when available.